Major accusations have been launched against ABC regarding the legitimacy of the debate— but are …
Read More »FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B
Washington — U.S. health regulators on Tuesday approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder. The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common form of the genetic disorder which primarily affects men. Currently, …
Read More »